Language And Country


14 Boulevard Royal L-2449 Luxembourg
Monday to Friday
8.30 am to 5 pm
Chaussée de La Hulpe, 120 – 1000 Brussels
Kortrijksesteenweg 218 – 9830 Sint-Martens-Latem
Monday to Friday
8.30 am to 4.30 pm

MENU - Mon Compte

Détail d'un fonds

Funds Detail

BL Equities Dividend

Theme fund

Data as of 10/06/2021

Risk level

Recommended investment horizon : > 6 years


Average annual performance since launch 6,03 %

Performance as at 10/06/2021

2018-2,11 %
201923,70 %
20200,93 %
Since 01/01/20217,95 %
Over the last 12 months12,38 %
Over 3 years32,25 %
Since launch121,91 %
Asset breakdown
Equities97,99 %
Cash2,01 %
Breakdown by currency
USD36,57 %
GBP24,78 %
CHF13,58 %
EUR4,51 %
SEK3,73 %
Others16,84 %
Main positions
Unilever PLC6,54 %
Philip Morris International Inc6,45 %
PepsiCo Inc6,16 %
Nestle SA nom5,24 %
Colgate Palmolive Co4,61 %


Investment objective and policy

The fund seeks long-term capital appreciation by investing in equities offering high dividend yields. BL-Equities Dividend invests in international companies whose current or expected dividend yield is higher than their benchmark index. There is no specific geographical, sector or monetary allocation. Companies are selected based on their valuation and intrinsic quality. This sub-fund is also available denominated in USD with the identical investment policy and performance figures (LU0751781666).

Management report - 1st Quarter 2021

In the first quarter of 2021, BL Equities Dividend gained 3.70% (retail accumulation share in euros, net of fees). During the period, we sold our entire holding in Roche in order to focus on better opportunities. These included significantly strengthening L'Oréal and Coloplast. L'Oréal is the world's leading beauty company (skincare, make-up, hair colour and haircare, perfumes) backed by a broad portfolio of strong brands with powerful histories (L'Oréal Paris, Lancôme, Yves Saint Laurent, Maybelline, Kiehl's, Kerastase, Armani, La Roche-Posay, NYX, Urban Decay, CeraVe, Redken, Garnier, Vichy, SkinCeuticals, Helena Rubinstein, Stylenanda, Valentino, etc.). Coloplast is the world leader in solutions for stoma and incontinence, its two main divisions. It has a share of around 40% in these oligopolistic markets. The group is also active in wound and skincare, as well as urology. Following these transactions, the fund is now concentrated on 32 high-quality companies that are protected by strong competitive advantages, generating a significant return on capital employed and healthy cashflow. They are companies in a sound financial position with robust growth prospects. At the end of the period, BL Equities Dividend offered a gross weighted average yield of 2.9% (cash included). The companies currently held in the fund post an average compound annual growth rate of their gross dividend per share of 8% over the last five years.

General information

Net Asset Value 
Calculated Every business day
NAV class B capitalisation shares (10/06/2021)221,91 EUR
NAV class A distribution shares (20/05/2021)218,12 EUR
CODESISIN capitalisation code : LU0309191657
ISIN distribution code : LU0309191491
WKN capitalisation code : A0MWCW
WKN distribution code : A0MWCV
Net assets (million)512,17 EUR
Launch date31/10/2007

Détail fonds - disclaimer

Before making any decision to subscribe, customers must ensure they have understood the product, having measured the risks associated with it and consulted their own advisers on the appropriateness of the product for their particular financial situation, taking into account legal, tax and accounting aspects. This fact sheet has been drawn up for information purposes and shall in no event be considered a solicitation to buy or an offer to sell securities or other financial instruments. Information provided to the interested party does not constitute legal or fiscal advice and the Bank shall not be held liable for such information. The securities referred to in this document may cause the investor to incur significant risk and may not be appropriate for all investors. Such risks include market risks, high volatility, credit risk, liquidity risk and interest-rate risk. There is no guarantee that the securities described in this document will achieve their investment objectives. Past performance is no indication of future returns. The Bank shall not be held liable for the future performance of these securities. Potential investors must ensure that they understand the risks of investing in such products and should only take an investment decision after giving careful consideration, together with their professional advisers, to the appropriateness of this investment to their specific financial situation, particularly with regard to legal, tax and accounting aspects. We have made every effort to verify that the information presented in this document is correct, in particular the estimated values, opinions and other estimates. Nevertheless, no guarantee can be given as to the validity, timeliness, completeness, correctness or accuracy of the information, which is provided for guidance only. Information may be subject to change without prior notice.

Page détail fonds - Retour au tableau